| Literature DB >> 29947682 |
Alana Costa Borges1, Paulo César de Almeida2, Stella Maria Torres Furlani3, Marcelo de Sousa Cury4, Douglas K Pleskow5.
Abstract
BACKGROUND: ERCP can lead to complications, which can be prevented by the recognition of risk factors. AIM: To identify these risk factors, with quality evaluation.Entities:
Mesh:
Year: 2018 PMID: 29947682 PMCID: PMC6049994 DOI: 10.1590/0102-672020180001e1348
Source DB: PubMed Journal: Arq Bras Cir Dig ISSN: 0102-6720
Results of all ERCPs performed
| n | (%) | Mean ± SD | |
| Deepcannulation | 189 | (89.6) | |
| Sphincterotomy | 142 | (67.3) | |
| Precut | 35 | (16.6) | |
| Endoscopist | 50 | (23.7) | |
| Number of undesired guidewire passage in PD | 139 | (65.9) | 1.1±2.5 |
| Number of undesired contrast injections in PD | 184 | (87.2) | 0.17±0.5 |
| Technical failure | 17 | (8.0) | |
| Prophylacticantibiotics | 12 | (5.7) | |
| Time (min) | 38.3±20.0 |
PD=pancreatic duct, SD=standard deviation
Profile of ERCPs due to choledocholithiasis
| n | (%) | |
| Stone size (mm) | 54 | (44.3) |
| Stone location | 117 | (95.9) |
| Extraction devices | 60 | (49.1) |
| Stone Extraction | 92 | (75.4) |
CBD=common bile duct
Early and late-onset post-ERCP complications
| Earlycomplications n(%) | Late complications n(%) | ||||
| Acutepancreatitis Mild Severe | 13 11 2 | (6.5) (5.5) (1.0) | Cholecystitis | 2 | (1.0) |
| Infection | 6 | (3.0) | Pneumonia | 2 | (1.0) |
| Sedation | 4 | (2.0) | Abdominal abscess | 1 | (0.5) |
| Bleeding Mild Severe | 3 1 2 | (1.5) (0.5) (1.0) | |||
| Fatality | 3 | (1.5) | |||
| Basket’simpaction | 1 | (0.5) | |||
| Paralyticileus | 1 | (0.5) | |||
| Duodenal perforation | 1 | (0.5) | |||
| Total | 32 | (16.0) | 5 | (2.5) | |
Dependent and independent risk factors for early post-ERCP complications
| Dependent risk factors | Independent risk factors | ||||||
| OR | CI95% | p | Adjusted OR* | CI95% | p | ||
| Fistulotomyprecut | 3.4 | 1.1 - 10.4 | 0.010 | Choledocholithiasis | 1.8 | 1.1 - 3.0 | 0.015 |
| >5 undesired guidewire passages in PD | 5.0 | 0.8 - 28.7 | 0.047 | ERCP duration>34 min (mean) | 2.7 | 1.1 - 6.8 | 0.041 |
| >1 contrastinjections in PD | 21.5 | 3.2 -142.7 | 0.002 | Cannulation time >7 min (mean) | 3.2 | 1.2 - 8.2 | 0.018 |
| ERCP duration>34min (mean) | 2.6 | 1.2 - 5.7 | 0.012 | ||||
| Attending’s procedural time >15min (mean) | 2.4 | 1.1 - 5.2 | 0.020 | ||||
| Cannulation time >7min (mean) | 3.4 | 1.5 - 7.8 | 0.002 | ||||
PD=pancreatic duct; *adjusted to gender, indication, precut, duration, attending’s procedural time, cannulation time